Berkeley, CA, United States of America

Keith C McFarland

This inventor holds 1 USPTO granted patent. Top assignee: Genentech, Inc.. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keith C McFarland. Retrieved from https://idiyas.com/inventor/keith-c-mcfarland

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keith C McFarland: Innovator in Hormonal Receptor Research

Introduction

Keith C McFarland is a notable inventor based in Berkeley, CA. He has made significant contributions to the field of hormonal receptor research. His work focuses on the purification and cloning of receptors that play crucial roles in human health.

Latest Patents

Keith holds a patent for the Luteinizing hormone/choriogonadotropin (LH/CG) receptor. This invention relates to the purification and cloning of receptors for luteinizing hormone, choriogonadotropin, follicle stimulating hormone, and thyroid stimulating hormone. The patent also addresses the uses of these molecules in the diagnosis and therapy of various human conditions. He has 1 patent to his name.

Career Highlights

Keith is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to medicine. His work at Genentech has allowed him to further his research and contribute to advancements in therapeutic solutions.

Collaborations

Throughout his career, Keith has collaborated with esteemed colleagues such as Karoly Nikolics and Deborah L Segaloff. These collaborations have enriched his research and expanded the impact of his inventions.

Conclusion

Keith C McFarland is a distinguished inventor whose work in hormonal receptor research has the potential to improve human health. His contributions to the field are noteworthy and continue to influence advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…